SBIR/STTR Research Award
CellRaft Arrays for Single-cell PCR
Award amount
$189,798Program and phase
SBIR · Phase IAward year
2014Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- CELL MICROSYSTEMS INC
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- G51EN7YDH7F3
- Solicitation number
- PA13-140
- Topic code
- NIBIB
Research abstract
DESCRIPTION (provided by applicant): Cell Microsystems is a start-up biotechnology company whose mission is to commercialize a cost effective platform for isolating and manipulating single, viable cells. The company's CellRaft(tm) technology is based on aunique cell array recently developed at the University of North Carolina (UNC) at Chapel Hill, and represents an ideal opportunity for the translation of an academic technology to the marketplace through the NIH sponsored SBIR partnership. In recognition of the growing market of single-cell genetic analysis, we will explore the feasibility of using the CellRaft technology as a sample handling tool for the analysis of single cells by polymerase chain reaction (PCR). The CellRaft(tm) technology is unique inenabling individual cells to be identified by a variety of selection critera followed by isolation with extremely high viability, purity, and yield. In this Phase I SBIR proposal, we will optimize the CellRaft(tm) Array for single-cell isolation towar
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Rapid identification and selection of functional antigen-specific monoclonalantibodies by FcGR-enabled screening on CellRaft Arrays in the CellRaft AIRSystem
- Rapid identification and selection of functional antigen-specific monoclonal antibodies by FcGR-enabled screening on CytoSort Arrays in the CellRaft AIR System
- Improving iPSC reprogramming and CRISPR gene editing workflows and efficacy using CellRaft technology
- Three-dimensional organoid culture using the CellRaft microwell technology
- THE THE PURPOSE OF THE PHASE II PROGRAM IS TO FOCUS ON DEVELOPING A T-CELL ACTIVATION PROTOCOL CONSISTENT WITH REPORTERCELL VIABILITY, DEVELOPING A PR
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Deep-UV Microscopy for Real-Time Adequacy Analysis of Bone Marrow Aspirates
- Deep learning image classification model for pediatric ear disease
- Development of a Multispectral Kerrison Rongeur for Dura and Nerve Root Detection
- Non Invasive Urine Output Monitor
- SoundScape: A portable small animal imager to accelerate drug development
Research funding history
19 SBIR/STTR records share this UEI (2013–2023). Reported award amounts total $15,051,342. Reported amounts are not federal obligations.
Phases: Phase I, Phase II, Phase II – Direct to Phase II
Agencies: Department of Health and Human Services